SCHEMBL41851

SCHEMBL41851

O=C1CC(=O)C(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL7264692 0.97 TDP2 (0.39)
Acetic Acid SCHEMBL16099585 0.84 ITGB3 (0.41)
Methacrylic Acid SCHEMBL5431596 0.78 ITGB3 (0.36)
SCHEMBL1509853 0.73
SCHEMBL407972 0.71
Hydrochloric Acid SCHEMBL10924919 0.70
SCHEMBL7657947 0.69
SCHEMBL5779557 0.69
SCHEMBL251099 0.69
SCHEMBL7704755 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 409 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119661520-A Dibenzo [ b ] [1,8] naphthyridine-subunit-pyrrolidine-2, 3, 5-trione compound and preparation method and application thereof 赣南师范大学 2025-03-21 CN claimed
WO-2023212179-A2 THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR UNIVERSITY OF MIAMI (US) 2023-11-02 WO claimed
US-20230137914-A1 nOMV-ANTIGEN CONJUGATED COMPOUNDS AND USE THEREOF GLAXOSMITHKLINE BIOLOGICALS, S.A. (BE) 2023-05-04 US claimed
US-20220008529-A1 MULTI-FUNCTIONALIZED noMV CONJUGATES GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2022-01-13 US claimed
EP-3799883-A1 NOMV-ANTIGEN CONJUGATED COMPOUNDS AND USE THEREOF GlaxoSmithKline Biologicals S.A. (BE) 2021-04-07 EP claimed
EP-3544637-B1 NATIVE OMV-ANTIGEN CONJUGATES AND USE THEREOF GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2020-11-11 EP claimed
EP-3664837-A1 MULTI-FUNCTIONALIZED nOMV CONJUGATES GlaxoSmithKline Biologicals S.A. (BE) 2020-06-17 EP claimed
EP-3544637-A1 nOMV-ANTIGEN CONJUGATES AND USE THEREOF GlaxoSmithKline Biologicals S.A. (BE) 2019-10-02 EP claimed
US-20190216847-A1 Biodegradable, Antioxidant, Thermally Responsive Injectable Hydrogel and Uses Therefor UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2019-07-18 US claimed
WO-2019030271-A1 MULTI-FUNCTIONALIZED nOMV CONJUGATES GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2019-02-14 WO claimed
WO-2009148554-A1 ACHIEVEMENT OF HIGH THERAPEUTIC INDEX THROUGH MOLECULAR IMAGING GUIDED TARGETED DRUG TREATMENT SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2009-12-10 WO claimed
US-20090136553-A1 TRIGGERABLY DISSOLVABLE HOLLOW FIBERS FOR CONTROLLED DELIVERY UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2009-05-28 US claimed
EP-1660091-B1 PYRIMIDINE-2,4-DIONE DERIVATIVES AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES INC (US) 2009-04-15 EP claimed
WO-2009042768-A1 TRIGGERABLY DISSOLVABLE HOLLOW FIBERS FOR CONTROLLED DELIVERY UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-04-02 WO claimed
EP-1646389-B1 PYRIMIDINE-2,4-DIONE DERIVATIVES AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES INC (US) 2008-09-10 EP claimed
US-20080096975-A1 A copolymer of an N-alkyl acrylamide, preferably N-isopropyl acrylamide, (meth)acrylic acid, and an amine-reactive group and having a polyester macromer in the backbone; cell growth substrates, wound healing drug delivery; fluid below room temperature, gelation at physiological temperature; nontoxic NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-04-24 US claimed
WO-2008045904-A2 THERMORESPONSIVE, BIODEGRADABLE, ELASTOMERIC MATERIAL UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-04-17 WO claimed
WO-2005115490-A2 NATURAL BIODEGRADABLE POLYSACCHARIDE COATINGS FOR MEICAL ARTICLES SURMODICS, INC. (US) 2005-12-08 WO claimed
EP-0946871-A1 METHOD OF COUPLING LIGANDS TO A SOLID PHASE IN ACIDIC SOLUTION AND ANIONIC SURFACTANT Orion-Yhtymä Oyj (FI) 1999-10-06 EP claimed
WO-1998027429-A1 METHOD OF COUPLING LIGANDS TO A SOLID PHASE IN ACIDIC SOLUTION AND ANIONIC SURFACTANT Orion-Yhtymä Oyj (FI) 1998-06-25 WO claimed